MYC DNA Methylation in Prostate Tumor Tissue is Associated with Gleason Score

In this publication, researchers investigate whether MYC DNA methylation at 8q24 (six CpG sites from exon 3 to the 3′ UTR) in prostate tumor was associated with tumor aggressiveness (based on Gleason score, GS), and incorporate RNA expression data to investigate the function. In preparation for the DNA methylation assays, the University of Maryland FFPE samples were sent to EpigenDx, Inc. (Hopkinton, MA, USA), where direct bisulfite treatment was performed on digested FFPE tissue.

View DNA Methylation Analysis →

Click below to View PDF

MYC DNA Methylation in Prostate Tumor--publication-EpigenDxIncreasing evidence suggests a role of epigenetic mechanisms at chromosome 8q24, an important cancer genetic susceptibility region, in prostate cancer. We investigated whether MYC DNA methylation at 8q24 (six CpG sites from exon 3 to the 3' UTR) in prostate tumor was associated with tumor aggressiveness (based on Gleason score, GS), and we incorporated RNA expression data to investigate the function. We accessed radical prostatectomy tissue for 50 Caucasian and 50 African American prostate cancer patients at the University of Maryland Medical Center, selecting an equal number of GS 6 and GS 7 cases per group. MYC DNA methylation was lower in tumor than paired normal prostate tissue for all six CpG sites (median difference: -14.74 to -0.20 percentage points), and we observed similar results for two nearby sites in The Cancer Genome Atlas (p < 0.0001). We observed significantly lower methylation for more aggressive (GS 7) than less aggressive (GS 6) tumors for three exon 3 sites (for CpG 212 (chr8:128753145), GS 6 median = 89.7%; GS 7 median = 85.8%; p-value = 9.4 10-4). MYC DNA methylation was not associated with MYC expression, but was inversely associated with PRNCR1 expression after multiple comparison adjustment (q-value = 0.04). Findings suggest that prostate tumor MYC exon 3 hypomethylation is associated with increased aggressiveness.

LET’S GET IN TOUCH

Please fill out the form below for more information about pricing and our customizable services.

CONTACT DETAILS

EpigenDx is a small company, and we work with each customer on a case-by-case basis to ensure that our services meet your project goals.

96 South Street
Hopkinton, MA 01748 U.S.A
Tel: (508) 497-9400
Toll Free: (800) 941-6884
Fax: (508) 497-9450